Vor Biopharma Inc. (VOR) Misses Q3 EPS by 12150c

Vor Biopharma Inc. (NASDAQ: VOR) reported Q3 EPS of ($121.60), $121.50 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.

You May Also Be Interested In

• Lyntris opens at $15.50, below IPO price of $17.50
• Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts
• Deere & Co. (DE) call put ratio 1 call to 1.7 puts into quarter results